Xilio Therapeutics, Inc. Uncategorized Contracts & Agreements
7 Contracts & Agreements
- Offer Letter, dated March 15, 2023, by and between Xilio Therapeutics, Inc. and Kevin Brennan (Filed With SEC on April 3, 2023)
- Letter Agreement, dated September 30, 2021, by and between the Registrant and Salvatore Giovine (Filed With SEC on March 1, 2022)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on March 1, 2022)
- Letter Agreement, dated September 30, 2021, by and between the Registrant and Martin Huber (Filed With SEC on October 1, 2021)
- Letter Agreement, dated May 24, 2019, by and between the Registrant and Joseph Farmer (Filed With SEC on October 1, 2021)
- Letter Agreement, dated September 30, 2021, by and between the Registrant and Ren Russo (Filed With SEC on October 1, 2021)
- Cross-License Agreement, dated as of December 16, 2020, by and between the Registrant and AskGene Pharma, Inc (Filed With SEC on October 1, 2021)